PhD candidate
Early-stage Researcher Manuela Amez Martin
RESEARCH
Glycosylation analysis of biopharmaceuticals
CURRICULUM VITAE
Manuela obtained a Master of Pharmacy from CEU San Pablo University (Madrid, Spain) in 2015. She worked at GSK in the Molecular Biology department within the R&D division investigating the substrate specificity of an essential Trypanosoma brucei deubiquitinase by SDS-PAGE, as well as at Roche and UCB in Drug Safety.
She joined the A4B consortium (an EU Horizon 2020 research and innovation programme) in May 2018 as a Marie Curie early stage researcher. She is currently persueing her PhD thesis under the supervision of Prof. Manfred Wuhrer (LUMC, The Netherlands) and is employed at CTI Clinical Trial and Consulting.
Publications
-
Serum and Plasma Immunoglobulin G Fc N-Glycosylation Is Stable during Storage
Manuela Amez Martín, Manfred Wuhrer, and David Falck
J. Proteome Res. 2021, 20, 5, 2935–2941, https://doi.org/10.1021/acs.jproteome.1c00148
-
Immunoglobulin G Glycoprofiles are Unaffected by Common Bottom-Up Sample Processing
Manuela Amez Martín, Manfred Wuhrer, and David Falck
J. Proteome Res. 2020, 19, 10, 4158–4162, https://doi.org/10.1021/acs.jproteome.0c00656
